Promising Drugs in Clinical Development To Treat Advanced Colorectal Cancer

摘要

Excluding skin cancers, colorectal cancer (CRC) is the third most common cancer diagnosed in men and women in the United States. Overall, the lifetime risk of developing the disease is approximately one in 21 (4.7%) for men and one in 23 (4.4%) for women. In the U.S., CRC is the second leading cause of cancer-related deaths in men and the third leading cause in women. According to the American Cancer Society, CRC is expected to cause more than 50,000 deaths in 2017.